Anticonvulsant effects of agomelatine in mice

Epilepsy and Behavior

Volumn 24, Issue 3, 2012, Pages 324-328

  Aguiar, Carlos Clayton Torres ^a   Almeida, Anália Barbosa ^b   Araújo, Paulo Victor Pontes ^b   Vasconcelos, Germana Silva ^b   Chaves, Edna Maria Camelo ^b   do Vale, Otoni Cardoso ^b   Macêdo, Danielle Silveira ^b   de Sousa, Francisca Cléa Florenço ^b   Viana, Glauce Socorro de Barros ^b   Vasconcelos, Silvânia Maria Mendes ^b  

^a UNIVERSITY OF FORTALEZA   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Agomelatine; Anticonvulsant effect; Electroshock stimulation; Melatonin; Picrotoxin; Pilocarpine; Seizure; Strychnine

Indexed keywords

ACETAMIDE DERIVATIVE; AGOMELATINE; ANTICONVULSIVE AGENT; CONVULSANT AGENT; MELATONIN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG POTENTIATION; FEMALE; MOUSE; SEIZURE; TIME;

ACETAMIDES; ANIMALS; ANTICONVULSANTS; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MELATONIN; MICE; SEIZURES; TIME FACTORS;

EID: 85027951198     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.04.134     Document Type: Article

References (33)

1. Hofstra, W.A., de Weerd, A.W., The circadian rhythm and its interaction with human epilepsy: a review of literature. Sleep Med Rev 13 (2009), 413–420.
2. Lapin, I.P., Mirzaev, S.M., Ryzov, I.V., Oxenkrug, G.F., Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J Pineal Res 24 (1998), 215–218.
3. Borowicz, K.K., Kaminski, R., Gasior, M., Kleinrok, Z., Czuczwar, S.J., Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur Neuropsychopharmacol 9 (1999), 185–190.
4. Lima, E., Cabral, F.R., Cavalheiro, E.A., Naffah-Mazzacoratti, M.G., Amado, D., Melatonin administration after pilocarpine-induced status epilepticus: a new way to prevent or attenuate postlesion epilepsy?. Epilepsy Behav 20 (2011), 607–612.
5. Dubovsky, S.L., Warren, C., Agomelatine, a melatonin agonist with antidepressant properties. Expert Opin Investig Drugs 18 (2009), 1533–1540.
6. Castel-Branco, M.M., Alves, G.L., Figueiredo, I.V., Falcao, A.C., Caramona, M.M., The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Methods Find Exp Clin Pharmacol 31 (2009), 101–106.
7. Velisek, L., Models of chemically-induced acute seizures. Models of seizures and epilepsy, 2006, Elsevier, 127–152.
8. Mares, P., Kubova, H., Electrical stimulation-induced models of seizures. Asla, P.P.A., Schwartzkroin, S.L., (eds.) Models of seizures and epilepsy, 2006, Elsevier, 159.
9. Buznego, M.T., Perez-Saad, H., Acute effect of an extract of Ambrosia paniculata (Willd.) O. E. Schultz (mugwort) in several models of experimental epilepsy. Epilepsy Behav 5 (2004), 847–851.
10. Czuczwar, S.J., Frey, H.H., Effect of morphine and morphine-like analgesics on susceptibility to seizures in mice. Neuropharmacology 25 (1986), 465–469.
11. Yemitan, O.K., Adeyemi, O.O., CNS depressant activity of Lecaniodiscus cupanioides. Fitoterapia 76 (2005), 412–418.
12. Buznego, M.T., Perez-Saad, H., Behavioral and antiepileptic effect of acute administration of the extract of the aquatic plant Echinodorus berteroi (Sprengel) Fassett (upright burhead). Epilepsy Behav 9 (2006), 40–45.
13. Luszczki, J.J., Swiader, M., Parada-Turska, J., Czuczwar, S.J., Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice. Neuropsychopharmacology 28 (2003), 1817–1830.
14. Champney, T.H., Hanneman, W.H., Legare, M.E., Appel, K., Acute and chronic effects of melatonin as an anticonvulsant in male gerbils. J Pineal Res 20 (1996), 79–83.
15. Banach, M., Gurdziel, E., Jedrych, M., Borowicz, K.K., Melatonin in experimental seizures and epilepsy. Pharmacol Rep 63 (2011), 1–11.
16. Albertson, T.E., Peterson, S.L., Stark, L.G., Lakin, M.L., Winters, W.D., The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 20 (1981), 61–66.
17. Peled, N., Shorer, Z., Peled, E., Pillar, G., Melatonin effect on seizures in children with severe neurologic deficit disorders. Epilepsia 42 (2001), 1208–1210.
18. Rosenstein, R.E., Chuluyan, H.E., Diaz, M.C., Cardinali, D.P., GABA as a presumptive paracrine signal in the pineal gland. Evidence on an intrapineal GABAergic system. Brain Res Bull 25 (1990), 339–344.
19. Golombek, D.A., Escolar, E., Burin, L.J., De Brito Sanchez, M.G., Fernandez, D.D., Cardinali, D.P., Chronopharmacology of melatonin: inhibition by benzodiazepine antagonism. Chronobiol Int 9 (1992), 124–131.
20. Millan, M.J., Gobert, A., Lejeune, F., et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306 (2003), 954–964.
21. San, L., Arranz, B., Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. Eur Psychiatry 23 (2008), 396–402.
22. Moezi, L., Shafaroodi, H., Hojati, A., Dehpour, A.R., The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Behav 22 (2011), 200–206.
23. Olsen, R.W., Bergman, M.O., Van Ness, P.C., et al. Gamma-aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites. Mol Pharmacol 19 (1981), 217–227.
24. Upton, N., Stean, T., Middlemiss, D., Blackburn, T., Kennett, G., Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents. Eur J Pharmacol 359 (1998), 33–40.
25. Solmaz, I., Gurkanlar, D., Gokcil, Z., Goksoy, C., Ozkan, M., Erdogan, E., Antiepileptic activity of melatonin in guinea pigs with pentylenetetrazol-induced seizures. Neurol Res 31 (2009), 989–995.
26. Kuhar, M., Yamamura, H.I., Localization of cholinergic muscarinic receptors in rat brain by light microscopic radioautography. Brain Res 110 (1976), 229–243.
27. Velisek, L., Veliskova, J., Moshe, S.L., Developmental seizure models. Ital J Neurol Sci 16 (1995), 127–133.
28. de Almeida-Paula, L.D., Costa-Lotufo, L.V., Silva, F.Z., et al. Melatonin modulates rat myotube-acetylcholine receptors by inhibiting calmodulin. Eur J Pharmacol 525 (2005), 24–31.
29. de, L.E., Soares, J.M. Jr., del Carmen Sanabria, G.Y., et al. Effects of pinealectomy and the treatment with melatonin on the temporal lobe epilepsy in rats. Brain Res 1043 (2005), 24–31.
30. Costa-Lotufo, L.V., Fonteles, M.M., Lima, I.S., et al. Attenuating effects of melatonin on pilocarpine-induced seizures in rats. Comp Biochem Physiol C Toxicol Pharmacol 131 (2002), 521–529.
31. Ray, M., Mediratta, P.K., Reeta, K., Mahajan, P., Sharma, K.K., Receptor mechanisms involved in the anticonvulsant effect of melatonin in maximal electroshock seizures. Methods Find Exp Clin Pharmacol 26 (2004), 177–181.
32. Vogel, H.G., Drug discovery and evaluation: pharmacological assays. 2008, Springer-Verlag Berlin Heidelberg, New York.
33. Loscher, W., Fassbender, C.P., Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8 (1991), 79–94.